Nonsteroidal anti-inabsmmatory agents and finasteride and risk for prostate cancer
✍ Scribed by Jacques Irani; Vincent Ravery; Jean-Louis Pariente; Emmanuel Chartier-Kastler; Eric Lechevallier; Michel Soulié; Dominique Chautard; Patrick Coloby; Eric Fontaine; Franck Bladou; François Desgrandchamps; Olivier Haillot
- Book ID
- 118643670
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 169 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1569-9056
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The association between use of aspirin and other nonsteroidal anti‐inflammatory drugs (NSAIDs) and the risk of prostate cancer remains controversial despite many observational epidemiological studies. We conducted a systematic meta‐analysis of these studies to examine both the strength
## Abstract Regular aspirin and non‐aspirin nonsteroidal anti‐inflammatory drug (NSAID) use is associated with a reduced risk of colorectal cancer. The effect of NSAIDs on the risk of other cancers remains unclear. To evaluate whether use of aspirin or other specific NSAIDs protects against lung ca
## Abstract Experimental studies suggest that NSAIDs could reduce prostate cancer risk. Results of observational studies on the relation between NSAIDs and prostate cancer risk have, however, been inconsistent. Moreover, none has addressed the issues of dosage, duration and timing of exposure. In a